Effect of Letrozole in Medical Abortio

Phase 3

Recruiting

• Conditions: medical abortion.

• Registration Number: IRCT20220522054961N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Any Pregnant Women
with Gestational Age Less than 14 Weeks
Candidate for Medical Abortion
with No Serious Comorbidities
No Recent or Recurrent Use of Corticosteroids
No History of and Allergy to Letrozol
No History of and Allergy to Misoprostol
Hemoglobin more than 10
Normal Coagulation and Complete blood count (CBC) test

Exclusion Criteria

Recurrent Abortion with Gestational Age Less than 14 weeks

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Complete Abortion Rate. Timepoint: Trans Vaginal Sonography for Remnant of Production will be Done in Patients Who Dispose of Pregnancy Products. Method of measurement: Complete Disposal of Pregnancy Products before 20 Weeks Gestational Age.;Incomplete Abortion Rate. Timepoint: Trans Vaginal Sonography for Remnant of Production will be Done in Patients Who Dispose of Pregnancy Products. Method of measurement: Incomplete Disposal of Pregnancy Products before 20 Weeks Gestational Age.;Amount of Vaginal Bleeding. Timepoint: 6 Hours Before and 6 Hours After Disposal of Pregnancy Products. Method of measurement: Number of Pads Used in an our.;Surgical Curettage Rate. Timepoint: When Incomplete Abortion Occur after Receiving One Course of Misoprostol based on FIGO Protocol. Method of measurement: The Number of Patients who Underwent Surgical Curettage.